Alexiou George A, Lianos Georgios, Fotakopoulos George, Michos Evaggelos, Pachatouridis Dimitrios, Voulgaris Spyridon
Department of Neurosurgery and.
Brain Inj. 2014;28(4):438-41. doi: 10.3109/02699052.2014.888769. Epub 2014 Feb 24.
Coagulopathy after traumatic brain injury (TBI) is a frequent event and is associated with patients' prognosis. TBI is also associated with a stress response that includes hyperglycemia. This study investigated if coagulopathy occurrence is associated with admission blood glucose levels in patients with TBI.
This study retrospectively evaluated patients with TBI who were admitted to a neurosurgical department over a 4-year period. Coagulopathy was defined as an aPTT >40 seconds and/or INR >1.2 and/or a platelet count <120*10(9) per litre.
One-hundred and forty-nine patients were included in the study. Thirty-four patients developed coagulopathy. Patients with coagulopathy had significantly lower haemoglobin levels, increased INR and increased aPTT. Patients with severe TBI had more frequent coagulopathy. Patients with severe TBI had significant higher serum glucose levels compared to patients with mild TBI. Using ROC curves it was found that a serum glucose of 151 mg dl(-1) was the threshold for the discrimination of patients that developed coagulopathy. Logistic regression analysis revealed that serum glucose greater than 151 mg dl(-1) and haemoglobin levels lower than 12.4 mg dL(-1) were significantly associated with coagulopathy occurrence.
Coagulopathy frequently occur after TBI. Patients with lower GCS score and lower haemoglobin levels and increased blood glucose levels at admission are at greater risk.
创伤性脑损伤(TBI)后的凝血病是常见事件,且与患者预后相关。TBI还与包括高血糖在内的应激反应有关。本研究调查了TBI患者凝血病的发生是否与入院血糖水平相关。
本研究回顾性评估了4年间入住神经外科的TBI患者。凝血病定义为活化部分凝血活酶时间(aPTT)>40秒和/或国际标准化比值(INR)>1.2和/或血小板计数<120×10⁹/升。
149例患者纳入研究。34例患者发生凝血病。凝血病患者的血红蛋白水平显著较低,INR升高,aPTT升高。重度TBI患者凝血病更常见。与轻度TBI患者相比,重度TBI患者的血清葡萄糖水平显著更高。通过ROC曲线发现,血清葡萄糖151mg/dl是区分发生凝血病患者的阈值。逻辑回归分析显示,血清葡萄糖大于151mg/dl和血红蛋白水平低于12.4mg/dL与凝血病的发生显著相关。
TBI后常发生凝血病。入院时格拉斯哥昏迷评分(GCS)较低、血红蛋白水平较低且血糖水平升高的患者风险更大。